In the pharmaceutical field, all marketing authorization holders are currently bound to implement the Delegated Regulation (EU) 2016/161 that completes the Directive 2001/83/EC laying down detailed provisions about the safety features displayed on the packaging of medications for human use, including the introduction of a two-dimensional barcode (an option that is still available with our SAFE79®). Until then, the pharmaceutical companies wishing to safeguard their products can avail themselves of our SAFE79® and apply it on both blister packs and boxes.
EUIPO (European Union Intellectual Property Office) also provides interesting data that would encourage an all-round protection:
- Counterfeiting causes a 4,4% drop in legitimate sales that is worth €10.2 billion
- 37.700 jobs lost in this field alone because of counterfeiting